NHS software supplier Realworld Health plots £100m London listing

An artificial intelligence-based firm which works with leading NHS hospitals including London’s Royal Free is plotting a listing on London’s junior stock market.

Sky News understands that Realworld Health has hired brokers from Finncap to prepare an AIM flotation that is expected to take place in the first quarter of next year.

City sources said the company was likely to target a £100m-plus valuation when it lists.

Previously called Draper & Dash, the business uses machine learning to anticipate patient flows in hospitals and drive cost-improvement programmes.

Its software is now used by a number of NHS trusts and large pharmaceutical companies.

RwHealth was founded by Orlando Agrippa, a former executive in the NHS and Australian healthcare sector, in 2017.

The company competes with the likes of Sensyne Health and Tempus.

Its emergence has come amid a debate about the growing use of private companies within the NHS, even as the COVID crisis has intensified pressure on the NHS to contend with a backlog in patient care.

“There is a clear need to transform how public health systems manage waiting lists, care delivery and review,” Mr Agrippa wrote in a recent LinkedIn post.

RwHealth declined to comment on a prospective flotation on Wednesday.